2022 Defibrotide-treated patients with anicteric or icteric veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic cell transplantation: an EBMT study Group Acute Leukemia Working Party (ALWP) 1st listed author Mohamad Mohty Journal Bone Marrow Transplant.
2022 Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Jesus Duque-Afonso Journal Bone Marrow Transplant.
2022 Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2022 Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Ryszard Swoboda Journal Bone Marrow Transplant.
2022 Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Am J Hematol.
2021 Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Frédéric Baron Journal Bone Marrow Transplant.
2021 Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jaime Sanz Journal J Hematol Oncol.
2021 Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Annalisa Ruggeri Journal Bone Marrow Transplant.
2021 Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Bhagirathbhai Dholaria Journal J Hematol Oncol.
2021 Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Abdul Hamid Bazarbachi Journal Clin Lymphoma Myeloma Leuk.
2021 Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry Group Acute Leukemia Working Party (ALWP) 1st listed author Roni Shouval Journal Lancet Haematol.
2021 Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Clin Cancer Res.